CAS 28845-86-5
:Acide 13,16,19-docosatriénoïque, (Z,Z,Z)-
- (13E,16E,19E)-docosa-13,16,19-trienoic acid
- (13Z,16Z,19Z)-13,16,19-Docosatrienoic acid
- 13,16,19-Docosatrienoic acid, (13Z,16Z,19Z)-
- 13,16,19-Docosatrienoic acid, (Z,Z,Z)-
- Docosa-13,16,19-Trienoic Acid
- cis-13,cis-16,cis-19-Docosatrienoic acid
13,16,19-Docosatrienoic acid, (13Z,16Z,19Z)-
CAS :Formule :C22H38O2Degré de pureté :99.0%Masse moléculaire :334.535913(Z),16(Z),19(Z)-Docosatrienoic acid
CAS :Formule :C22H38O2Degré de pureté :>99%Couleur et forme :LiquidMasse moléculaire :334.54(13Z,16Z,19Z)-13,16,19-Docosatrienoic Acid
CAS :Produit contrôléFormule :C22H38O2Couleur et forme :NeatMasse moléculaire :334.54Docosatrienoic acid
CAS :Docosatrienoic acid (DTA) is a polyunsaturated fatty acid that belongs to the group of docosatetraenoic acids. It has been shown to have anti-tumor, anti-inflammatory, and neuroprotective activities in mice. DTA was also found to inhibit the expression of inflammatory cytokines and downregulate the production of reactive oxygen species. This compound has been shown to be effective against nephropathy in women who undergo hemodialysis or renal transplantation procedures. DTA inhibits the activity of malonic acid decarboxylase, an enzyme involved in fatty acid synthesis that produces malonic acid from acetyl-CoA, thereby preventing the production of polyunsaturated fatty acids such as arachidonic acid. DTA also inhibits the activity of gamma-aminobutyric acid transaminase, which converts gamma-aminobutyric acid into succinic semialdehyde, thus preventing its conversion into
Formule :C22H38O2Degré de pureté :Min. 95%Masse moléculaire :334.54 g/molDocosatrienoic Acid
CAS :Docosatrienoic acid is a rare omega-3 fatty acid; Ki value is 5×M, which inhibits the binding of LTB4 to porcine neutrophil membrane.Formule :C22H38O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :334.54




